ArticleBMC pediatrics2026

Comparing the impact of blinatumomab therapy versus standard chemotherapy on the progression of relapsed/refractory pediatric B-ALL: a two-center retrospective cohort study.

Aziz Eghbali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.